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In Auvergne, a cattle-raising area in central
France, brucellosis control measures have been
strictly observed since 1965, and systematic
vaccination was stopped in 1983. Active
surveillance is conducted on the basis of clinical
findings (abortions or orchitis) and an annual
serologic test performed for every animal (rose
bengal plate agglutination test or complement
fixation test); abortions and orchitis have to be
bacteriologically confirmed. When infected
animals are detected, a second test on a new
sample drawn 2 weeks later is required for
confirmation. When an animal on a farm is
infected, the herd is slaughtered. This  policy has
resulted in a dramatic decrease in the prevalence
of brucellosis, and very few cases were reported
in 1988 (1). In 1988, however, several animals
had positive tests for brucellosis. These positive
reactions apparently were associated with an
epizootic due to Yersinia enterocolitica O:9. The
bacterium was isolated from the stools of cattle
and goats in infected herds (2).
Yersinia enterocolitica O:9 shares antigens
with Brucella abortus, and misdiagnosis can
occur because both bacteria produce positive
reactions with the Wright agglutination test and
immunofluorescent assay (brucellosis) and the
agglutination test (yersiniosis) (3). The clinical,
biological, and epidemiologic features of the two
diseases, however, are quite different. In the
1988 epizootic, Yersinia infection, commonly
called atypical brucellosis, affected a few young
cattle (<2 years of age) and did not spread to the
whole herd. No increase in abortion was noted,
the titer of antibodies declined rapidly, and no
reaction to the Brucellallergene (Rhone Merieux
OCB) dermal test was observed. Epidemiologic
and serologic surveillance of infected herds
found no evidence of brucellosis infection and
allowed restoring them to noninfected status
after several months. Epidemiologic surveillance
demonstrated that brucellosis decreased, whereas
yersiniosis continued to spread  throughout the
region in the 1990s (Figure 1).
Before the 1988 epizootic, Y. enterocolitica
human infections were rare in Auvergne. In a
1980-81 survey of infections due to Yersinia
species, five patients had antibodies against
Y. enterocolitica O:3, the serogroup commonly
found in Europe in this period (4,5). No more
than three cases of Y. enterocolitica infection
were recorded each year at the University
Hospital laboratory during 1982 to 1990: none
had the serotype O:9. Two cases of human
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Yersinia enterocolitica O:9 infections were reported in Auvergne in 1988 to 1989,
while brucellosis due to Brucella abortus was almost eliminated. The serologic cross-
reactions between the two bacteria complicated the diagnosis of brucellosis cases. In
1996, human cases of Yersinia enterocolitica O:9 infection were detected, with a peak
incidence of 12 cases. Veterinary surveillance could have predicted the emergence of
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Figure 1. Annual incidence of cattle brucellosis and
yersiniosis, Auvergne, France, 19891997. Figure 2. Yersinia enterocolitica O:9 infections in
humans, Auvergne, France, 19901998.
autochthonous brucellosis were  detected in 1988
to 1990; in both cases, brucellosis had been detected
in the patients cattle a few months before.
Awareness of Yersinia infection was height-
ened in the regional teaching hospital, but
systematic surveillance for patients with
diarrhea or abdominal symptoms could not be
established. The first human case was detected
in 1991; this patient also had positive serologic
results for brucellosis but no history of contact
with Brucella-infected animals; gastrointestinal
symptoms suggested yersiniosis (5). Since then,
the number of human cases diagnosed in
Auvergne has increased, despite the lack of
systematic screening for Yersinia infection.
Human yersiniosis cases were defined by clinical
symptoms (fever, gastrointestinal symptoms,
arthritis,  erythema nodosum) associated with a
positive serologic test for brucellosis and lack of
contact with Brucella-infected animals.
In 1996, a retrospective study was done
among regional medical laboratories to identify
positive brucellosis serologic tests from April
1995 to March 1996. Of eight cases detected, six
met criteria for yersiniosis and two had evidence
of past brucellosis. Through the end of 1998, 42
cases were recorded, with a peak incidence of
12 cases in 1996 (Figure 2). Gastrointestinal
symptoms were found in 35 (83%) patients:
diarrhea alone in eight, abdominal pain in six
(four patients had surgery [6]), and both in 21.
Twelve patients had fever with no other
symptoms when they sought medical attention
(7), six had arthritis in one or several joints (two
with sacroilieitis), and five had erythema
nodosum. The diagnosis of the last 18 cases was
confirmed with an enzyme-linked immunosor
bent assay (ELISA) developed and performed by
the Laboratoire de Reference des Yersinia of
Institut Pasteur. This new ELISA, which uses
microtitration plates coated with plasmid-
encoded  Yersinia outer proteins (YOP), is more
specific than the agglutination test (8). The
results matched the clinical diagnosis of
yersiniosis and were consistently negative in
patients with brucellosis (six recent or past cases
with a positive Wright agglutination test) tested
in the same period. Stool samples were negative
except for one, but in most cases, gastrointestinal
symptoms disappeared before the patients were
admitted to the hospital. None of these patients
had had contact with Brucella-infected animals.
Only six were cattle breeders, and seven had
recent contact with animals through work or
travel. We suspect that most of the patients
acquired Yersinia through foodborne transmis-
sion. Two patients may have eaten the same
cheese, although bacteriologic analysis of the
cheese could not be performed. Serologic tests for
yersiniosis  and brucellosis were done for both
patients; one was positive for Brucella, the other
for  Yersinia. Second specimens were both
positive for Yersinia by the agglutination test
and the new YOP ELISA test.
Yersinia enterocolitica infection is a protean
disease (5). Gastrointestinal symptoms are the
most frequent. In our series, many patients
sought medical attention for persistent fever,
night sweats, or secondary features of the
disease (7); digestive symptoms were prominent
in their history. At this stage of the disease,
Yersinia could not be isolated from stools. As the
common serologic tests (positive either with
Y. enterocolitica or with Brucella antigens) were721 Vol. 5, No. 5, SeptemberOctober 1999 Emerging Infectious Diseases
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not useful, the absence of contact with animals
infected with brucellosis was an indication of
yersiniosis. Diagnosis could be confirmed by
positive YOP ELISA.
The 1996 Yersinia epizootic in Auvergne
preceded an increase in human cases in central
France, where no cases of Y. enterocolitica O:9
had previously been detected. The epizootic
demonstrates that such emerging disease can be
predicted by veterinary surveillance data (9).
Acknowledgments
The authors gratefully acknowledge the help of E. Carniel
(Centre de Référence des Yersinia, Institut Pasteur, Paris).
References
    1. Douzal Y. Policy of prevention against bovine
brucellosis. Actual results. Medecine et Maladies
Infectieuses 1993;23(S):507-12.
  2. Reynaud A, Delmas C, Vidon JM, Marty-Garrec M,
Dubourdieu V. Presence of Yersinia enterolitica O:9 in
fecal samples of Brucella abortus ruminants revealing
atypical serological reactions against antigens. Medecine
et Maladies Infectieuses 1993;23(S):516-9.
    3. Kittelberger R, Reichel MP, Joyce MA, Skaak C.
Serological crossreactivity between Brucella abortus
and  Yersinia enterocolitica O:9. III. Specificity of the in
vitro antigen-specific gamma interferon test for bovine
brucellosis diagnosis in experimentally Yersinia
enterocolitica O:9-infected cattle. Vet Microbiol
1997;57(4):361-71.
  4. Verhaegen J, Charlier J, Lemmens P, Delmee M, Van
Noyen R, Verbist L, et al. Surveillance of human
Yersinia enterocolitica infections in Belgium: 1967-
1996. Clin Infect Dis 1998;27(1):59-64.
  5. Bottone  EJ.  Yersinia enterocolitica: the charisma
continues. Clin Microbiol Rev 1997;10(2):257-276.
  6. Shorter NA, Thompson MD, Mooney DP, Modlin JF.
Surgical aspects of an outbreak of Yersinia enterocolitis.
Pediatr Surg Int 1998;13(1):2-5.
  7. de Kleijn EM, van Lier HJ, van der Meer JW. Fever of
unknown origin (FUO). II. Diagnostic procedures in a
prospective multicenter study of 167 patients. The
Netherlands FUO Study Group. Medicine
1997;76(6):401-14.
  8. Benoit C, Guiyoule A, Carniel E. Serodiagnosis of human
pathogenic Yersinia. Presse Med 1996;25:1627-30.
    9. Tauxe RV. Emerging foodborne diseases: an evolving
public health challenge. Emerg Infect Dis 1997;3(4):425-34.